According to IMARC Group’s latest report, titled “Choroidal Neovascularization Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global choroidal neovascularization market to exhibit moderate growth during the next five years.
Choroidal neovascularization (CNV) refers to the formation of new blood vessels in the eyes' choroid layer that affects the Bruch’s membrane and retinal pigment epithelium (RPE). It can occur due to several reasons, such as age-related macular degeneration, excess secretion of vascular endothelial growth factor, and numerous inflammatory diseases of choroid and retina. Some of the primary symptoms of CNV include lipid exudation, sub-retinal blood and fluid, loss of vision, color disturbances, waviness, and black spots in the central vision. Currently, various procedures, such as fluorescein angiography (FA), indo-cyanine green (ICG) angiography, and optical coherence tomography (OCT) scanning, are being adopted to diagnose CNV.
Request for a free sample copy of this report:
https://www.imarcgroup.com/choroidal-neovascularization-market/requestsa...
Market Trends
The global market for CNV treatment is driven by the growing occurrences of ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears, etc. Furthermore, the rising geriatric population who are more vulnerable to severe eye-based disorders is also augmenting the market growth. Furthermore, several improvements in healthcare facilities, along with the increasing investments in extensive R&D activities in the medical sector, are also catalyzing the global market.
Explore full report with table of contents: https://www.imarcgroup.com/choroidal-neovascularization-market
Choroidal Neovascularization Market 2020-2025 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Bausch Health Companies Inc.
Bayer AG
Gilead Sciences Inc.
Hoffmann-La Roche Ltd.
MaaT Pharma
Novartis AG
Pfizer Inc.
Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited)
Regeneron Pharmaceuticals Inc.
Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.)
The report has segmented the market on the basis of product type, type of diagnosis, treatment type, application and region.
Breakup by Product Type:
Intravenous
Intravitreal
Breakup by Type of Diagnosis:
Fluorescein Angiography (FA)
Indocyanine Green (ICG) Angiography
Spectral Domain Optical Coherence Tomography (OCT)
Others
Breakup by Treatment Type:
Angiogenesis Inhibitors Injection
Photodynamic Therapy
Laser photocoagulation
Low-dose Radiation Therapy
Surgery
Breakup by Application:
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Browse Related Report:
Intracranial Pressure Monitoring Market Report: https://www.imarcgroup.com/intracranial-pressure-monitoring-market
Guidewires Market Report: https://www.imarcgroup.com/guidewires-market
Remote Patient Monitoring Market Report: https://www.imarcgroup.com/remote-patient-monitorning-market
Hemostats Market Report: https://www.imarcgroup.com/hemostats-market
Telehealth Market Report: https://www.imarcgroup.com/telehealth-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group